Equities

Aarey Drugs and Pharmaceuticals Ltd

AAREYDRUGS:NSI

Aarey Drugs and Pharmaceuticals Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)47.10
  • Today's Change0.50 / 1.07%
  • Shares traded14.11k
  • 1 Year change+65.26%
  • Beta--
Data delayed at least 15 minutes, as of Apr 19 2024 10:53 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • AAREYDRUGS:NSI price falls below 200-day moving average to 46.20 at 11:57 BST
  • AAREYDRUGS:NSI price falls below 50-day moving average to 46.30 at 12:48 BST
  • AAREYDRUGS:NSI price moved over -2.49% to 47.00
  • AAREYDRUGS:NSI price rises above 50-day moving average to 47.25 at 12:51 BST
  • AAREYDRUGS:NSI price falls below 200-day moving average to 46.05 at 10:26 BST
  • AAREYDRUGS:NSI trading volume exceeds daily average by +20.44%
  • AAREYDRUGS:NSI price falls below 50-day moving average to 46.80 at 10:23 BST
  • AAREYDRUGS:NSI price rises above 15-day moving average to 47.85 at 13:53 BST
  • AAREYDRUGS:NSI price falls below 15-day moving average to 46.30 at 12:48 BST
  • AAREYDRUGS:NSI price rises above 15-day moving average to 47.25 at 12:51 BST

Key statistics

On Friday, Aarey Drugs and Pharmaceuticals Ltd (AAREYDRUGS:NSI) closed at 47.10, 78.07% above the 52 week low of 26.45 set on Apr 19, 2023.
52-week range
Today
26.45Apr 19 202368.00Jan 04 2024
Open47.95
High48.00
Low46.50
Bid--
Offer--
Previous close46.60
Average volume29.94k
Shares outstanding28.05m
Free float14.19m
P/E (TTM)28.03
Market cap1.31bn INR
EPS (TTM)1.66
INR
Data delayed at least 15 minutes, as of Apr 19 2024 10:53 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.